Differentiation-Promoting Activity of Pomegranate (Punica granatum) Fruit Extracts in HL-60 Human Promyelocytic Leukemia Cells

Journal of Medicinal Food

Volumn 7, Issue 1, 2004, Pages 13-18

  Kawaii, Satoru ^a   Lansky, Ephraim P ^b  

^a TOKYO DENKI UNIVERSITY   (Japan)

^b Rimonest Ltd   (Israel)

Author keywords

Breast cancer; Chemoprevention; Flavonoid; Prostate cancer

Indexed keywords

ESTERASE; FLAVONOID; NONSPECIFIC ESTERASE; PLANT EXTRACT; POLYPHENOL;

ARTICLE; BREAST CANCER; CANCER PREVENTION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN HL 60; CONTROLLED STUDY; ENZYME ACTIVITY; FRUIT; FRUIT JUICE; HUMAN; HUMAN CELL; LEUKEMIA CELL; POMEGRANATE; PRIORITY JOURNAL; PROSTATE CANCER;

CELL DIFFERENTIATION; CELL DIVISION; ESTERASES; FERMENTATION; FLAVONOIDS; HL-60 CELLS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; PHAGOCYTOSIS; PHENOLS; PHYTOTHERAPY; PLANT EXTRACTS; PUNICACEAE;

LYTHRACEAE; PUNICA GRANATUM;

EID: 1842423822     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/109662004322984644     Document Type: Article

References (45)

1. Spira AI, Carducci MA: Differentiation therapy. Curr Opin Pharmacol 2003;3:338-343.
2. Lo Coco F, Zelent A, Kimchi A, Carducci M, Gore SD, Waxman S: Progress in differentiation induction as a treatment for acute promyelocytic leukemia and beyond. Cancer Res 2002;62: 5618-5621.
3. Wang Z, Sun G, Shen Z, Chen S, Chen Z: Differentiation therapy for acute promyelocytic leukemia with all-trans retinoic acid: 10-year experience of its clinical application. Chin Med J (Engl) 1999;112:963-967.
4. Aksentijevich I, Flinn IW: Chronic lymphocytic leukemia: advances in biology and therapeutics. Curr Opin Oncol 2003;15: 16-22.
5. Parmar S, Tallman MS: Acute promyelocytic leukaemia: a review. Expert Opin Pharmacother 2003;4:1379-1392.
6. Sciarra A, Casale P, Di Chirio C, Di Nicola S, Di Silverio F: New aspects on prostate cancer: hereditary form, developmental estrogenization and differentiation therapy. Minerva Urol Nefrol 1998;50:185-190.
7. Walczak J, Wood H, Wilding G, Williams T Jr, Bishop CW, Carducci M: Prostate cancer prevention strategies using antiproliferative or differentiating agents. Urology 2001;57:81-85.
8. Myers CE: Differentiating agents and nontoxic therapies. Urol Clin North Am 1999;26:341-351, ix.
9. Yang Q, Sakurai T, Kakudo K: Retinoid, retinoic acid receptor beta and breast cancer. Breast Cancer Res Treat 2002;76: 167-173.
10. Baj G, Arnulfo A, Deaglio S, Mallone R, Vigone A, Rosa M, Giana M, Villa L, Malavasi F, Surico N: Retinoids in breast cancer prevention and treatment. A review of the literature. Eur J Gynaecol Oncol 2000;21:411-415.
11. Patnaik A, Rowinsky EK, Villalona MA, Hammond LA, Britten CD, Siu LL, Goetz A, Felton SA, Burton S, Valone FH, Eckhardt SG: A phase 1 study of pivaloyloxymethyl butyrate, a prodrug of the differentiating agent butyric acid, in patients with advanced solid malignancies. Clin Cancer Res 2002;8:2142-2148.
12. DiGiovanna JJ: Retinoids for the future: oncology. J Am Acad Dermatol 1992;27(6 Pt 2):S34-S37.
13. Tallman MS, Wiernik PH: Retinoids in cancer treatment. J Clin Pharmacol 1992;32:868-888.
14. Guyton KZ, Kensler TW, Posner GH: Vitamin D and vitamin D analogs as cancer chemopreventive agents. Nutr Rev 2003;61: 227-238.
15. Klamt F, Dal-Pizzol F, Roehrs R, de Oliveira RB, Dalmolin R, Henriques JA, de Andrades HH, de Paula Ramos AL, Saffi J, Moreira JC: Genotoxicity, recombinogenicity and cellular preneoplasic transformation induced by vitamin A supplementation. Mutat Res 2003;539:117-125.
16. Bray BJ, Goodin MJ, Inder RE, Rosengren RJ: The effect of retinol on hepatic and renal drug-metabolising enzymes. Food Chem Toxicol 2001;39:1-9.
17. Ortiz MA, Bayon Y, Lopez-Hernandez FJ, Piedrafita FJ: Retinoids in combination therapies for the treatment of cancer: mechanisms and perspectives. Drug Resist Updat 2002:5; 162-175.
18. Havsteen BH: The biochemistry and medical significance of the flavonoids. Pharmacol Ther 2002;96:67-202.
19. Zand RS, Jenkins DJ, Diamandis EP: Steroid hormone activity of flavonoids and related compounds. Breast Cancer Res Treat 2000;62:35-49.
20. Fawzy AA, Vishwanath BS, Franson RC: Inhibition of human non-pancreatic phospholipases A2 by retinoids and flavonoids. Mechanism of action. Agents Actions 1988;25:394-400.
21. Lagarrigue S, Chaumontet C, Heberden C, Martel P, Gaillard-Sanchez I: Suppression of oncogene-induced transformation by quercetin and retinoic acid in rat liver epithelial cells. Cell Mol Biol Res 1995;41:551-560.
22. Kang SN, Lee MH, Kim KM, Cho D, Kim TS: Induction of human promyelocytic leukemia HL-60 cell differentiation into monocytes by silibinin: involvement of protein kinase. Biochem Pharmacol 2001;61:1487-1495.
23. Zi X, Agarwal R: Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: implications for prostate cancer intervention. Proc Natl Acad Sci U S A 1999;96:7490-7495.
24. Tyagi A, Agarwal C, Agarwal R: The cancer preventive flavonoid silibinin causes hypophosphorylation of Rb/p107 and Rb2/p130 via modulation of cell cycle regulators in human prostate carcinoma DU 145 cells. Cell Cycle 2002;1:137-142.
25. DeFeudis FV, Papadopoulos V, Drieu K: Ginkgo biloba extracts and cancer: a research area in its infancy. Fundam Clin Pharmacol 2003;17:405-417.
26. Collins SJ: Some perspectives on dietary inhibition of carcinogenesis: studies with curcumin and tea. Proc Soc Exp Biol Med 1997;216:234-245.
27. Kawaii S, Tomono Y, Katase E, Ogawa K, Yano M: Effect of citrus flavonoids on HL-60 cell differentiation. Anticancer Res 1999;19:1261-1269.
28. Kawaii S, Tomono Y, Katase E, Ogawa K, Yano M: HL-60 differentiating activity and flavonoid content of the readily extractable fraction prepared from citrus juices. J Agric Food Chem 1999;47:128-135.
29. Csokay B, Prajda N, Weber G, Olah E: Molecular mechanisms in the antiproliferative action of quercetin. Life Sci 1997;60: 2157-2163.
30. Takahashi T, Kobori M, Shinmoto H, Tsushida T: Structure-activity relationships of flavonoids and the induction of granulocytic- or monocytic-differentiation in HL60 human myeloid leukemia cells. Biosci Biotechnol Biochem 1998;62:2199-2204.
31. Miyake M, Arai N, Ushio S, Iwaki K, Ikeda M, Kurimoto M: Promoting effect of kaempferol on the differentiation and mineralization of murine pre-osteoblastic cell line MC3T3-E1. Biosci Biotechnol Biochem 2003;67:1199-1205.
32. Senderowicz AM: Development of cyclin-dependent kinase modulators as novel therapeutic approaches for hematological malignancies. Leukemia 2001;15:1-9.
33. van Elswijk DA, Schobel UP, Lansky EP, Irth H, Van der Greef J: Rapid dereplication of estrogenic compounds in pomegranate (Punica granatum) using on-line biochemical detection coupled to mass spectrometry. Phytochemistry 2004;65:233-241.
34. Kim ND, Mehta R, Yu W, Neeman 1, Livney T, Amichay A, Poirier D, Nicholls P, Kirby A, Jiang W, Mansel R, Ramachandran C, Rabi T, Kaplan B, Lansky E: Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer. Breast Cancer Res Treat 2002;71:203-217.
35. Hora JJ, Maydew ER, Lansky, EP, Dwivedi C: Chemopreventive effects of pomegranate seed oil on skin tumor development in CD1 mice. J Med Food 2003;6:157-161.
36. Toi M, Bando H, Ramachandran C, Melnick SJ, Imai A, Fife RS, Carr RE, Oikawa T, Lansky EP: Preliminary studies on the antiangiogenic potential of pomegranate fractions in vitro and in vivo. Angiogenesis 2004;6:121-128.
37. Newburger PE, Chovaniec ME, Greenberger JS, Cohen HJ: Functional changes in human leukemic cell line HL-60. A model for myeloid differentiation. J Cell Biol 1979;82:315-322.
38. Koeffler HP, Golde DW: Human myeloid leukemia cell lines: a review. Blood 1980;56:344-350.
39. Schubert SY, Lansky EP, Neeman I: Antioxidant and eicosanoid enzyme inhibition properties of pomegranate seed oil and fermented juice flavonoids. J Ethnopharmacol 1999;66: 11-17.
40. Wink M: Evolution of secondary metabolites from an ecological and molecular phylogenetic perspective. Phytochemistry 2003;64: 3-19.
41. Honma Y, Ishii Y, Yamamoto-Yamaguchi Y, Sassa T, Asahi K: Cotylenin A, a differentiation-inducing agent, and IFN-alpha cooperatively induce apoptosis and have an antitumor effect on human non-small cell lung carcinoma cells in nude mice. Cancer Res 2003;63:3659-3666.
42. Honma Y: Cotylenin A - a plant growth regulator as a differentiation-inducing agent against myeloid leukemia. Leuk Lymphoma 2002;43:1169-1178.
43. Schwalm K, Aloni R, Langhans M, Heller W, Stich S, Ullrich CI: Flavonoid-related regulation of auxin accumulation in Agrobacterium tumefaciens-induced plant tumors. Planta 2003;218: 163-178.
44. Refojo D, Liberman AC, Giacomini D, Carbia Nagashima A, Graciarena M, Echenique C, Paez Pereda M, Stalla G, Holsboer F, Arzt E: Integrating systemic information at the molecular level: cross-talk between steroid receptors and cytokine signaling on different target cells. Ann N Y Acad Sci 2003; 992:196-204.
45. Schubert SY, Neeman 1, Resnick N: A novel mechanism for the inhibition of NF-kappaB activation in vascular endothelial cells by natural antioxidants. FASEB J 2002;16:1931-1933.